Pharmacodynamics and potential toxicity of intranasally administered dipyrone.
Dipyrone is a non-narcotic analgesic and antipyretic drug used in both pediatric and adult patients. Dipyrone solution can be used intranasally as an antipyretic agent for infants. However, dipyrone is not stable in liquid state. Therefore, a stable dipyrone formulation was developed and the antipyretic effect of the formulation was studied after intranasal administration in rabbits and rats, respectively. To guarantee dose accuracy in animal studies, effect of dose volume on the distribution of dipyrone solution in rabbit nasal cavities were studied, using gentian violet as an indicator. Animal fever model and intranasal administration methods were established. In addition, the potential toxicity of the dipyrone formulation was studied. It was shown that the nasal volume of rabbits is large enough to hold 100 microl solution. After intranasal administration, improved pharmacodynamics was obtained with the new developed dipyrone formulation compared to the normal dipyrone solution, and significantly decreased body temperature was observed 10 min after dosing. The toxicity was negligible. In conclusion, the dipyrone formulation is effective and safe for clinical medication.
Mao
Shirui
S
College of Pharmacy, Shenyang Pharmaceutical University, China. mao@staff.uni-marburg.de
Yang
Shiling
S
Bi
Dianzhou
D
D000281:Administration, Intranasal; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000633:toxicity; D001831:Body Temperature / Q000187:drug effects; D004177:Dipyrone / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000633:toxicity*; D008297:Male; D023421:Models, Animal; D009297:Nasal Mucosa / Q000187:drug effects*; D011817:Rabbits
D000894:Anti-Inflammatory Agents, Non-Steroidal; D004177:Dipyrone